MMP9 and systemic sclerosis: SSc patients with the diffuse type (n = 23) and had higher concentrations of MMP-9 than those with the limited type (n = 19) (364.6 ± 32.4 ng/ml versus 260.0 ± 34.6 ng/ml, P = 0.034) (Fig. 2).